SKYX

SKYX has genuinely commercialized — revenue scaled from $32K in FY2022 to $92.0M in FY2025 — but that is where the good news stops. Growth has collapsed to +6.6% YoY while total expenses of $121.1M still dwarf $92.0M of revenue, producing a -$29.1M operating loss and a -31.6% operating margin. The gross margin is only 19.6%, so even at much higher volume the current cost base ($25.7M selling/marketing + $31.2M G&A) leaves no visible path to breakeven. This is a business whose top line is decelerating precisely when it most needs to inflect toward profit.

The balance sheet is the disqualifier. Stockholders' equity is negative at -$4.59M against a -$216M accumulated deficit, so liabilities-to-equity is meaningless (-12.49x). Cash is just $8.05M and fell 36.3% in a year, while operating cash flow was -$13.3M — under a year of runway on the current burn. Current assets ($15.4M) trail current liabilities ($24.6M), so working capital is negative too. The company is solvent only because it continuously issues equity and debt: the MD&A discloses $5.6M via ATM, $29.3M of common stock, $5.4M of preferred, and $5.3M of convertible notes raised across 2025–January 2026. Shares outstanding rose 27.6% in one year, and 8% cumulative preferred dividends (rising to 12% if unpaid) plus convertibles sit ahead of common holders — a structural drain that dilutes any equity upside.